Desh Rakshak Aushdhalaya Current Share Price | Desh Rakshak Aushdhalaya Stock Screener
DESHRAK
Pharmaceuticals
Desh Rakshak Aushdhalaya Current Stock Price Today
Track the current Desh Rakshak Aushdhalaya share price and stock price live with TickJournal's free stock screener.
Browse Desh Rakshak Aushdhalaya annual reports to support your investment research.
Use the Desh Rakshak Aushdhalaya stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Desh Rakshak Aushdhalaya Market Cap
₹15.30 Cr.
DESHRAK P/E Ratio (TTM)
27.73
Desh Rakshak Aushdhalaya P/B Ratio
1.18
EPS (TTM)
₹0.99
Dividend Yield
-
Debt to Equity
0.30
DESHRAK 52 Week High
-
Desh Rakshak Aushdhalaya 52 Week Low
-
Operating Margin
24.00%
Profit Margin
14.29%
DESHRAK Revenue (TTM)
₹7.00
EBITDA
₹1.00
Net Income
₹1.00
Total Assets
₹21.00
Total Equity
₹13.00
Desh Rakshak Aushdhalaya Current Share Price Chart
Track the current Desh Rakshak Aushdhalaya share price and stock price with an interactive chart. Analyse DESHRAK price trends, trading volume, historical performance, and volatility across different timeframes — the complete Desh Rakshak Aushdhalaya stock quote in one place.
Desh Rakshak Aushdhalaya Company Profile - Fundamental Screener
Screen Desh Rakshak Aushdhalaya company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for DESHRAK shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE971E01016
Desh Rakshak Aushdhalaya Balance Sheet Screener
Screen DESHRAK balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 21 | 18 | 16 | 16 | 16 | 15 | 12 | 11 | 11 | 10 |
| Current Assets | 11 | 8 | 6 | 5 | 6 | 6 | 4 | 4 | 4 | 4 |
| Fixed Assets | 10 | 8 | 8 | 8 | 8 | 7 | 5 | 4 | 4 | 4 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 3 | 3 | 3 | 4 | 4 | 3 | 2 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 13 | 10 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 7 |
| Share Capital | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 7 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 3 | 3 |
Desh Rakshak Aushdhalaya Income Statement Screener - Profit & Revenue Analysis
Screen Desh Rakshak Aushdhalaya income statement and profit fundamentals.
Analyze DESHRAK quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Desh Rakshak Aushdhalaya share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 7 | 6 | 6 | 6 | 6 | 7 | 5 | 6 | 5 | 5 | 5 | 5 |
| Expenses | 5 | 6 | 5 | 5 | 5 | 5 | 6 | 4 | 5 | 4 | 4 | 4 | 4 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 24.00% | 19.00% | 20.00% | 21.00% | 21.00% | 19.00% | 14.00% | 15.00% | 14.00% | 14.00% | 13.00% | 14.00% | 14.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 1.00 | 0.99 | 1.07 | 0.96 | 0.91 | 1.08 | 0.95 | 0.69 | 0.76 | 0.64 | 0.63 | 0.00 | 0.05 |
Desh Rakshak Aushdhalaya Cash Flow Screener - Liquidity Fundamentals
Screen DESHRAK cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 2 | 0 | 0 | 1 | 1 | -1 | 0 | 0 | 1 |
| Investing Activities | 0 | 0 | -1 | -2 | -1 | -1 | 0 | 0 | -1 | -1 |
| Financing Activities | 0 | -1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 |
Desh Rakshak Aushdhalaya Shareholding Pattern Screener
See Desh Rakshak Aushdhalaya shareholding pattern with promoter, FII, and DII holdings.
Check Desh Rakshak Aushdhalaya promoter holding and ownership changes for DESHRAK on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.03% | 50.03% | 64.28% | 50.07% | 50.07% | 50.03% | 64.28% | 64.28% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 49.83% | 49.84% | 35.64% | 49.84% | 49.84% | 49.84% | 35.65% | 35.65% |
| Other Holding | 0.14% | 0.14% | 0.07% | 0.09% | 0.09% | 0.14% | 0.06% | 0.06% |
| Shareholder Count | 2,393 | 2,391 | 2,353 | 2,428 | 2,429 | 2,411 | 2,352 | 2,351 |
Desh Rakshak Aushdhalaya Share Dividend Screener - Share Yield Analysis
Check Desh Rakshak Aushdhalaya dividend history with payout and yield data.
View Desh Rakshak Aushdhalaya dividend details including ex-dates and amounts for DESHRAK stock.
Desh Rakshak Aushdhalaya Stock Index Membership
See which indices include Desh Rakshak Aushdhalaya stock.
Check DESHRAK index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Desh Rakshak Aushdhalaya Market Events Screener - Corporate Actions
Get Desh Rakshak Aushdhalaya corporate actions including splits, bonuses, and buybacks.
Check Desh Rakshak Aushdhalaya stock events that may affect DESHRAK share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-12-30 | 2026-12-30 | Annual General Meeting | NA | -9.09% |
| 2026-09-25 | 2026-09-25 | Annual General Meeting | NA | 0.00% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | -3.74% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 15.74% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | -9.52% |
| 2025-12-06 | 2025-12-06 | Quarterly Result Announcement | NA | -4.86% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 4.75% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -3.95% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -1.99% |
| 2025-05-29 | 2025-05-29 | Extraordinary General Meeting | NA | 12.83% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | 27.53% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 0.00% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 0.00% |
Desh Rakshak Aushdhalaya Competitors Screener - Peer Comparison
Screen DESHRAK competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 454,674 | 37.60 | 61,674 | 12.69% | 11,565 | 43.86 |
| Divis Laboratories | 247,284 | 82.59 | 11,067 | 13.95% | 2,568 | 69.30 |
| Torrent Pharmaceuticals | 186,913 | 85.57 | 13,886 | 20.34% | 2,138 | 48.63 |
| Zydus Life Science | 116,411 | 24.35 | 27,658 | 17.64% | 5,026 | 53.47 |
| Cipla | 112,694 | 33.34 | 29,045 | 2.24% | 3,870 | 40.26 |
| Laurus Labs | 101,315 | 91.18 | 6,868 | 22.01% | 890 | 59.31 |
| Lupin | 96,247 | 17.39 | 29,039 | 26.75% | 5,356 | 25.45 |
| Mankind Pharma | 95,732 | 46.52 | 14,636 | 14.85% | 1,938 | 37.67 |
| Aurobindo Pharma | 95,513 | 25.64 | 34,145 | 5.56% | 3,503 | 55.93 |
| Dr Reddys Laboratories | 95,503 | 30.26 | 35,059 | 3.90% | 4,158 | 37.04 |
Desh Rakshak Aushdhalaya Company Announcements - News Screener
Screen DESHRAK latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-06 | Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-09-01 | Intimation Regarding Book Closure | - |
| 2026-09-01 | Intimation Regarding Record Date | - |
| 2026-09-01 | Intimation Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-09-01 | Intimation Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-09-01 | Reg. 34 (1) Annual Report. | - |
| 2026-09-01 | Submission Of Notice Of 45Th Annual General Meeting As Per Regulation 34 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-27 | Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Para A Of Part A Of Schedule III And Reg 30 Of The SEBI (LODR) Reg 2015 | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Statement Of No Deviation(S) Or Variation(S) In The Use Of Proceeds And Utilization Of Funds Relating To Allotment Of Equity Shares On Preferential Basis Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Reg 2015 | - |
| 2026-08-13 | Submission Of Quarterly And Year To Date Unaudited Financial Results For The Quarter Ended 30Th June 2026 As Per Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 13Th Day Of August 2026 Pursuant To Para A Of Part A Of Schedule III And Regulation 30 Of The SEBI (LODR) Reg 2015 | - |
| 2026-08-09 | Board Meeting Intimation for Pre Intimation Of The Board Meeting As Per Regulation 29 Of The SEBI (Listing Obligations & Disclosure Requirements) Reg 2015 And Closure Of Trading Window | - |
| 2026-07-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-27 | Closure of Trading Window | - |
| 2026-06-23 | Announcement under Regulation 30 (LODR)-Change in RTA | - |
| 2026-06-18 | Announcement under Regulation 30 (LODR)-Change in RTA | - |
| 2026-06-18 | Announcement under Regulation 30 (LODR)-Change in RTA | - |